Arvee Laboratories (India) Limited
Quick Take
- • Trading at 47.4× trailing earnings
- • Moderate ROE at 12.0%
- • Low leverage (D/E 0.03)
- • No dividend data
- • Operating margin 12.6% · Net margin 9.8%
- • Profit growth +926.70% YoY · Beta 0.55
Latest quarter · Jun 2026
| ₹ Cr | Jun 2026 | QoQ | YoY |
|---|---|---|---|
| Revenue | 17 | +54.55% | +142.86% |
| Operating Profit | 3 | +200.00% | +200.00% |
| Net Profit | 2 | +100.00% | — |
| EPS (₹) | 1.54 | +227.66% | +926.67% |
About the company
From latest AR & concallArvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also provides drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4amino pyridine, and 2chloro5nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
